Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IUB PRIMA
- Development stage
- Preclinical
- Lead developer
- OCON Therapeutics
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Intrauterine
01
Overview
IUB PRIMA is an intrauterine drug-delivery system developed as a targeted, controlled-release platform for the local treatment of uterine disorders. It utilizes OCON Therapeutics' proprietary IntraUterine Ball (IUB) 3D frame technology, which is designed to fit the uterine cavity and minimize risks such as malposition and perforation. The device delivers low-dose therapies directly to the uterus, aiming to reduce systemic side effects associated with oral or parenteral drugs. Its initial application is for long-term reversible contraception and management of heavy menstrual bleeding by locally releasing levonorgestrel into the uterine cavity. The platform also serves as a proof-of-concept for future targeted treatments of endometriosis and myomas/uterine fibroids using other drugs[2][4][6].
- Brand names
- IUB PRIMA
- Other names
- IUB PRIMAIUB PRIMA 3D stent drug delivery frame
02
Targets
PR (Progesterone receptor)
Beyond the preview
Go deeper on IUB PRIMA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IUB PRIMA.